2016, Número 3
<< Anterior Siguiente >>
Rev Invest Clin 2016; 68 (3)
Globe salvage with intra-arterial topotecan-melphalan chemotherapy in children with a single eye
Leal-Leal CA, Asencio-López L, Higuera-Calleja J, Bernal-Moreno M, Bosch-Canto V, Chávez-Pacheco J, Isaac-Otero G, Beck-Popovic M
Idioma: Ingles.
Referencias bibliográficas: 23
Paginas: 137-142
Archivo PDF: 113.75 Kb.
RESUMEN
Sin resumen.
REFERENCIAS (EN ESTE ARTÍCULO)
Abramson DH, Schefler A. Update on Retinoblastoma. Retina. 2004;24:828-48.
Secretaría de Salud. Diagnóstico y Manejo de Retinoblastoma. MEXICO: SECRETARIA DE SALUD; 2013.
Abramson DH, Dunkel IJ, Brodie SE, Marr B, Gobin YP. Superselective ophthalmic artery chemotherapy as primary treatment for retinoblastoma (chemosurgery). Ophthalmology. 2010;117: 1623-9.
Abramson DH, Dunkel IJ, Brodie SE, Kim JW, Gobin YP. A phase I/II study of direct intraarterial (ophthalmic artery) chemotherapy with melphalan for intraocular retinoblastoma initial results. Ophthalmology. 2008;115:1398-404.
Friedrich MJ. Retinoblastoma therapy delivers power of chemotherapy with surgical precision. JAMA. 2011;305:2276-8.
Shields CL, Mashayekhi A, Au AK, et al. The International Classification of Retinoblastoma predicts chemoreduction success. Ophthalmology. 2006;113:2276-80.
Shields CL, Bianciotto CG, Jabbour P, et al. Intra-arterial chemotherapy for retinoblastoma: report No. 1, control of retinal tumors, subretinal seeds, and vitreous seeds. Arch Ophthalmol. 2011;129:1399-406.
Gobin YP, Dunkel IJ, Marr BP, Brodie SE, Abramson DH. Intraarterial chemotherapy for the management of retinoblastoma: four-year experience. Arch Ophthalmol. 2011;129:732-7.
Ellsworth RM. The practical management of retinoblastoma. Trans Am Ophthalmol Soc. 1969;67:462-534.
Kaneko A, Suzuki S. Eye preservation treatment of retinoblastoma with vitreous seeding. Jpn J Clin Oncol. 2003;33:601-7.
Abramson DH, Fabius AW, Issa R, et al. Advanced unilateral retinoblastoma: The impact of ophthalmic artery chemosurgery on enucleation rate and patient survival at MSKCC. PLoS One. 2015;10:e0145436.
Schaiquevich P, Ceciliano A, Millan N, et al. Intra-arterial chemotherapy is more effective than sequential periocular and intravenous chemotherapy as salvage treatment for relapsed retinoblastoma. Pediatr Blood Cancer. 2013;60:766-70.
Abramson DH, Marr BP, Dunkel IJ, et al. Intra-arterial chemotherapy for retinoblastoma in eyes with vitreous and/or subretinal seeding: 2-year results. Br J Ophthalmol. 2012;96:499-502.
Grigorovski N, Lucena E, Mattosinho C, et al. Use of intra-arterial chemotherapy for retinoblastoma: results of a survey. Int J Ophthalmol. 2014;7:726-30.
Leal-Leal CA. Retinoblastoma. In: Rivera-Luna R (ed). El Niño Con Cáncer. Los Padecimientos Más Comunes Para El Médico No Especialista. México: ETM; 2007:123-136.
Schaiquevich P, Buitrago E, Ceciliano A, et al. Pharmacokinetic analysis of topotecan after superselective ophthalmic artery infusion and periocular administration in a porcine model. Retina. 2012;32:387-95.
Schaiquevich P, Buitrago E, Taich P, et al. Pharmacokinetic analysis of melphalan after superselective ophthalmic artery infusion in preclinical models and retinoblastoma patients. Invest Ophthalmol Vis Sci. 2012;53:4205-12.
Abramson DH. Benefits and risks of intraarterial chemotherapy for retinoblastoma: An Update. Retina Today; Nov-Dec 2011.
Binaghi M, Zerlauth JB, Beck Popovic M, Munier F. Efficacy of intra- arterial ophthalmic artery chemotherapy for retinoblastoma in children : 3-years Lausanne experience. 99th Annual Meeting of the Swiss Society of Radiology. Lausanne, Switzerland; 2012.
Marr BP, Brodie SE, Dunkel IJ, Gobin YP, Abramson DH. Threedrug intra-arterial chemotherapy using simultaneous carboplatin, topotecan and melphalan for intraocular retinoblastoma: preliminary results. Br J Ophthalmol. 2012;96:1300-3.
Monroy J, Orbach D, VanderVeen D. Complications of intra-arterial chemotherapy for retinoblastoma. Semin Ophthalmol. 2014;29:429-33.
Instituto Nacional de Estadística y Geografía (INEGI). http:// www.inegi.org.mx.
Shields C, Shields J. New strategies in the treatment of unilateral sporadic retinoblastoma. J Pediatr Ophthalmol Strabismus. 2015;52:134-7.